RNAi Crop Protection Market Size, Share & Trends Analysis, by Mode of Action, Application Method, Crop Type, and Geography - Global Forecast to 2036

RNAi Crop Protection Market Size & Forecast

The global RNAi crop protection market was valued at USD 0.10 billion in 2025. The market is projected to reach USD 7.07 billion by 2036, growing from USD 0.15 billion in 2026 at a CAGR of 47.2% during the forecast period (2026–2036).

Key Highlights

• The global RNAi crop protection market is projected to reach USD 7.07 billion by 2036.
• The market is expected to grow at a CAGR of 47.2% during the forecast period 2026–2036.
• The total RNAi crop protection market was valued at USD 0.10 billion in 2025 and is estimated to reach USD 0.15 billion in 2026.
• North America is expected to dominate this market with the largest revenue share in 2026, supported by the presence of the first EPA registered sprayable RNAi biopesticide, the commercial scale of RNAi trait corn already planted across millions of acres, and the concentration of RNAi crop protection developers headquartered in the United States.
• Asia Pacific is projected to witness the fastest revenue growth during the forecast period, driven by rising insecticide resistance in major food crops, growing government support for biopesticide adoption in China and India, and expanding biotechnology investment across the region's agricultural sector.
• By mode of action, the host induced gene silencing segment is expected to hold the largest share of the market in 2026, driven by the embedded, trait based delivery of RNAi already commercialized in corn rootworm control and its integration into existing seed distribution and royalty systems.
• By mode of action, the spray induced gene silencing segment is projected to register the highest growth during the forecast period, driven by its applicability across a far broader range of crops without the regulatory and breeding timelines associated with transgenic trait development.
• By application method, the seed treatment and embedded trait segment is expected to account for the largest share of the market in 2026, reflecting the scale of RNAi trait corn already under commercial cultivation.
• By application method, the foliar spray segment is projected to register the highest growth during the forecast period, driven by new product registrations, ease of integration into existing spray equipment, and applicability to specialty and horticultural crops where trait development is not commercially viable.
• By crop type, the field crops segment is expected to account for the largest share in 2026, while the fruits and vegetables segment is projected to register the highest CAGR during the forecast period.
• By geography, North America is expected to dominate the market in 2026, while Asia Pacific is expected to witness the fastest growth during the forecast period.

RNAi Crop Protection Market Overview

Click here to: Get Free Sample Pages

The global RNAi crop protection market encompasses pest, disease, and weed management products that silence specific genes in target organisms rather than relying on broad-spectrum chemical toxicity. The market includes sprayable double-stranded RNA (dsRNA) formulations applied through foliar, soil, or trunk treatments, as well as RNAi traits incorporated into seeds for host-induced gene silencing (HIGS). Applications span insect pest control, nematode and disease management, and emerging weed-control technologies across field crops, fruits and vegetables, cereals and grains, and oilseeds and pulses.

Following ingestion or uptake, dsRNA is processed by the target organism's RNA interference machinery into small interfering RNAs (siRNAs), which guide the degradation or suppression of complementary messenger RNA and disrupt genes essential to survival, development, or reproduction. The sequence-specific mechanism enables developers to target particular pests while potentially reducing impacts on non-target organisms compared with broad-spectrum chemistries.

Regulatory progress is strengthening market adoption. In December 2023, the U.S. EPA registered ledprona, the active ingredient in GreenLight Biosciences' Calantha, as the first sprayable dsRNA biopesticide approved for use on a food crop, targeting Colorado potato beetle. IRAC subsequently established Group 35: RNA interference (RNAi), recognizing RNAi as a distinct insecticide mode of action. In parallel, Bayer's SmartStax PRO corn technology represents a major commercial deployment of HIGS-based RNAi for western corn rootworm.

Market growth is supported by substantial global crop losses from pests and diseases, increasing resistance to conventional insecticides, and tighter restrictions on certain chemical active ingredients. However, high dsRNA production costs, formulation and delivery challenges, environmental stability, variable uptake, regulatory complexity, and the relatively narrow target specificity of individual RNAi products remain key constraints.

Continued investment in scalable dsRNA manufacturing, improved delivery technologies, and collaborations between agrochemical companies and RNAi-focused biotechnology firms is expected to reduce production costs and expand RNAi crop protection across additional crops and target pests during the forecast period.

RNAi Crop Protection Market Growth Drivers

First Commercial Regulatory Approvals Validating RNAi as a Distinct Pesticide Mode of Action

The registration of the first sprayable double stranded RNA biopesticide by the U.S. Environmental Protection Agency in December 2023 represents a foundational turning point for the RNAi crop protection market, converting a technology that had existed largely in research and field trial settings into a commercially registered product category. GreenLight Biosciences' Calantha, built on the ledprona active ingredient, required more than four years of EPA evaluation, an experimental use permit spanning field trials across ten states, and a formal public comment period before registration, establishing the review pathway that subsequent sprayable RNAi products are expected to follow.

The Insecticide Resistance Action Committee's creation of a dedicated mode of action group for ledprona formally distinguishes RNAi from every existing chemical insecticide class, giving growers a genuinely new resistance management tool at a time when resistance to established chemistries continues to erode the effectiveness of conventional pest control programs. Parallel to the sprayable product pathway, RNAi trait corn targeting western corn rootworm has been commercially planted in the United States since 2022 as part of the SmartStax PRO trait stack developed by Bayer and Corteva, giving the host induced gene silencing segment several years of commercial planting history and demonstrated grower adoption ahead of the newer sprayable format. Together, these two approval milestones are shifting industry and grower perception of RNAi from an emerging research concept to a proven, registrable crop protection technology, encouraging further investment and pipeline development across both established agrochemical companies and specialized RNAi biotechnology firms.

Evolving International Regulatory Frameworks Shaping Market Access Beyond the United States

The pace at which RNAi crop protection products gain approval outside the United States is one of the most significant factors shaping the market's near term growth trajectory, given that the technology does not fit cleanly into either the conventional chemical pesticide or the earlier generation genetically modified crop regulatory pathways used in most jurisdictions. The European Food Safety Authority has taken a structured approach to this gap, issuing updated 2025 guidance specifically addressing the risk assessment of RNAi based genetically modified plants, covering the bioinformatic analysis required to confirm the intended silencing trait and identify potential off-target effects, alongside dietary exposure assessment requirements for food and feed derived from RNAi trait crops. This guidance builds on the existing framework under the EU's plant protection product and GMO regulations, which continue to govern the authorization of both RNAi based plant protection products and RNAi trait crops in the region.

At the international level, the Organisation for Economic Co-operation and Development has published guidance specific to the human health risk assessment of externally applied double stranded RNA pesticides, providing a reference framework that regulatory authorities in multiple jurisdictions are drawing on as they build their own review processes for this product category. The European and Mediterranean Plant Protection Organization has similarly contributed methodological guidance supporting the assessment of RNA based active substances under existing plant protection product regulation. As these frameworks mature and more regulatory authorities establish clear review pathways, RNAi developers are expected to expand product submissions beyond the United States, broadening the addressable geography for both sprayable and trait based RNAi products over the forecast period.

Rising Pest Resistance and Crop Loss Pressure Reinforcing Demand for Precision Gene Silencing Tools

The persistent scale of global crop losses attributable to pests, diseases, and weeds continues to underpin long-term demand for new pest management technologies, including RNAi. The Food and Agriculture Organization of the United Nations estimates that pests and diseases account for the loss of between 20 and 40 percent of global crop production annually, with associated economic costs exceeding USD 220 billion a year from plant diseases alone and a further USD 70 billion attributable to invasive insect species. This scale of loss, sustained over decades despite widespread conventional pesticide use, reflects the growing challenge posed by resistance development in target pest populations exposed repeatedly to a limited number of chemical modes of action.

RNAi technology is positioned by developers as a tool that can specifically address resistant pest populations by targeting genetic sequences unique to a given species, reducing the likelihood of cross-resistance with existing chemistries. The Colorado potato beetle, the target pest of the first EPA approved sprayable RNAi product, is itself a well-documented example of a species that has developed resistance to numerous conventional insecticide classes over repeated growing seasons, illustrating the practical resistance management gap that RNAi products are being developed to fill. As resistance pressure continues to build against established chemistries across other major pest species, crop protection companies are expanding RNAi pipeline investment to target additional insect, fungal, and nematode pests where conventional options are becoming less effective.

RNAi Crop Protection Market Analysis: Top Segments

By Mode of Action: In 2026, the Host Induced Gene Silencing Segment to Dominate the Global RNAi Crop Protection Market

Based on mode of action, the RNAi crop protection market is segmented into host induced gene silencing and spray induced gene silencing. In 2026, the host induced gene silencing segment is expected to account for the largest share of this market. The leading position of this segment is attributed to the multi-year commercial planting history of RNAi trait corn under the SmartStax PRO trait stack developed by Bayer and Corteva, which has been cultivated across meaningful corn acreage in the United States since 2022 for control of western corn rootworm, and to the segment's integration into existing seed distribution, licensing, and royalty structures that give it a substantially larger installed commercial base than sprayable RNAi products at this stage of the market's development.

However, the spray induced gene silencing segment is projected to register the highest growth during the forecast period. The high growth of this segment is driven by its applicability to a far broader range of crops than trait based approaches, since sprayable dsRNA products can be applied to specialty and horticultural crops where the cost and multi-year timeline of trait development and deregulation are not commercially viable, by the precedent set by the EPA registration of Calantha as a foliar applied biopesticide, and by the ability of developers to bring new pest specific formulations to market on shorter development cycles than transgenic trait programs typically require.

By Application Method: In 2026, the Seed Treatment and Embedded Trait Segment to Hold the Largest Share

Based on application method, the RNAi crop protection market is segmented into seed treatment and embedded trait, foliar spray, soil and drench treatment, and trunk and stem injection. In 2026, the seed treatment and embedded trait segment is expected to account for the largest share of this market. The growth of this segment is driven by the scale of RNAi trait corn already under commercial cultivation for corn rootworm control, and by the efficiency of delivering season-long, systemic gene silencing protection through the seed itself rather than through repeated field applications.

However, the foliar spray segment is projected to register the highest growth during the forecast period. The high growth of this segment is driven by the ease of integrating dsRNA sprays into existing crop protection application equipment and spray programs already used by growers, by expanding regulatory approvals following the Calantha registration, and by the segment's applicability to fruit, vegetable, and other specialty crops that fall outside the economic scope of trait development programs.

By Crop Type: In 2026, the Field Crops Segment to Hold the Largest Share

Based on crop type, the RNAi crop protection market is segmented into field crops, fruits and vegetables, cereals and grains, oilseeds and pulses, and other crop types. In 2026, the field crops segment is expected to account for the largest share of this market, reflecting the scale of RNAi trait corn planted for rootworm control across major corn producing regions of the United States and the concentration of large agrochemical company research investment in row crop pest management.

However, the fruits and vegetables segment is projected to register the highest growth during the forecast period. The high growth of this segment is driven by the commercial precedent set by Calantha's approval for use on potato crops against the Colorado potato beetle, by the comparatively higher value per acre of fruit and vegetable production that supports premium biopesticide pricing, and by the limited availability of new chemical pest control options in specialty crop systems where many older chemistries face use restrictions.

Geographical Analysis

Based on geography, the overall RNAi crop protection market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2026, North America is expected to account for the largest share of this market. This position is driven by the United States being the first and, to date, primary market with EPA registered sprayable RNAi products and commercially planted RNAi trait corn, by the concentration of RNAi crop protection developers including GreenLight Biosciences, RNAissance Ag, AgroSpheres, and Pebble Labs headquartered in the United States, and by the presence of the large-scale corn, soybean, and potato growing regions that represent the primary commercial target crops for currently approved and pipeline RNAi products.

However, the Asia Pacific RNAi crop protection market is expected to grow at the fastest rate from 2026 to 2036. The rapid growth of this market is driven by rising resistance to conventional insecticides across major pest species affecting rice, vegetable, and fruit crops in China and India, growing government interest in biopesticide adoption as an alternative to broad spectrum chemical pesticides, and expanding agricultural biotechnology research investment across China, Japan, South Korea, and India. The region's large and diverse base of specialty and horticultural crop production is also expected to create demand for foliar RNAi products suited to crops where trait based approaches are not commercially applicable.

Europe represents a market shaped primarily by the pace of regulatory clarity for RNAi based products under the existing plant protection product and genetically modified organism frameworks. The European Food Safety Authority's 2025 guidance on the risk assessment of RNAi based genetically modified plants, together with supporting methodological work from the Organisation for Economic Co-operation and Development and the European and Mediterranean Plant Protection Organization, is expected to progressively clarify the pathway for both RNAi trait crops and RNAi based plant protection products in the region, supporting gradual market development as products move through review.

The Middle East and Africa and Latin America regions represent early stage markets for RNAi crop protection, with Latin America's development supported primarily by the scale of soybean, corn, and fruit production in Brazil and Argentina, where interest in RNAi trait crops and biopesticides is building alongside broader adoption of biological crop protection products across the region's agricultural sector.

Key Companies

The global RNAi crop protection market remains at an early and highly fragmented stage, comprising diversified agrochemical companies developing RNAi-based crop protection technologies and specialized biotechnology companies focused on RNA-based pest and disease management. Key competitive differentiators include proprietary dsRNA production and delivery platforms, breadth of target pests and crops, regulatory capabilities, commercial development pipelines, and partnerships that combine RNAi technology with the field-testing, registration, manufacturing, and distribution capabilities of established agricultural companies.

Large agrochemical companies, including Bayer AG, Syngenta Group, Corteva, Inc., BASF SE, and FMC Corporation, participate through RNAi research, trait development, technology partnerships, and broad crop-protection commercialization capabilities. Bayer has established a leading position through commercial RNAi corn traits, while FMC has strengthened its position through its collaboration and investment in AgroSpheres to accelerate the development of RNA-based crop protection solutions.

Specialized RNAi developers, including GreenLight Biosciences, AgroSpheres, Renaissance BioScience Corp., RNAissance Ag LLC, Pebble Labs, Inc., PlantArcBio Ltd., Genolution Inc., Innatrix, and TRILLIUM AG, compete through proprietary RNA production, formulation, delivery, and gene-silencing technologies. GreenLight Biosciences has a particularly advanced commercial position following U.S. EPA registration of its RNA-based Calantha bioinsecticide and subsequent regulatory expansion into Europe. Renaissance BioScience is also expanding its yeast-based RNAi platform toward soil-dwelling pests and developing advanced RNA production and delivery technologies.

Tropic Biosciences UK Ltd. participates primarily through gene-silencing and gene-editing technologies, while Sumitomo Chemical Co., Ltd. represents a major diversified agricultural-input company with potential for RNAi expansion through technology development and partnerships. Nufarm Limited, ICL Group Ltd., UPL Limited, and other agricultural-input companies are better considered secondary or adjacent participants rather than core RNAi competitors.

The report provides a comprehensive competitive analysis based on key players' product portfolios, technology capabilities, geographic presence, partnerships, regulatory developments, and strategic initiatives undertaken during the past few years.

Key players analyzed in the global RNAi crop protection market include Bayer AG (Germany), Syngenta Group (Switzerland), Corteva, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), GreenLight Biosciences, Inc. (U.S.), AgroSpheres, Inc. (U.S.), Renaissance BioScience Corp. (Canada), RNAissance Ag LLC (U.S.), Pebble Labs, Inc. (U.S.), PlantArcBio Ltd. (Israel), Genolution Inc. (South Korea), Innatrix (U.S.), Tropic Biosciences UK Ltd. (U.K.), and TRILLIUM AG (U.S.), among others.

RNAi Crop Protection Market Research Summary

Key Questions Answered in the Report